SAR and QSAR research on tyrosinase inhibitors using machine learning methods

References

• A. Sanchez-Ferrer, J.N. Rodriguez-Lopez, F. Garcia-Canovas, and F. Garcia-Carmona, Tyrosinase: A comprehensive review of its mechanism, BBA-Protein Struct. M. 1247 (1995), pp. 1–11. doi:10.1016/0167-4838(94)00204-T.
   PubMed Web of Science ®Google Scholar
• W.T. Ismaya, H.J. Rozeboom, A. Weijn, J.J. Mes, F. Fusetti, H.J. Wichers, and B.W. Dijkstra, Crystal structure of Agaricus bisporus mushroom tyrosinase: Identity of the tetramer subunits and interaction with tropolone, Biochemistry-US 50 (2011), pp. 5477–5486. doi:10.1021/bi200395t.
   PubMed Web of Science ®Google Scholar
• I. Kubo, I. Kinst-Hori, S.K. Chaudhuri, Y. Kubo, Y. Sánchez, and T. Ogura, Flavonols from heterotheca inuloides: Tyrosinase inhibitory activity and structural criteria, Bioorg. Med. Chem. 8 (2000), pp. 1749–1755. doi:10.1016/S0968-0896(00)00102-4.
   PubMed Web of Science ®Google Scholar
• C. Olivares, J.C. Garcia-Borron, and F. Solano, Identification of active site residues involved in metal cofactor binding and stereospecific substrate recognition in mammalian tyrosinase. implications to the catalytic cycle, Biochemistry 41 (2002), pp. 679–686. doi:10.1021/bi011535n.
   PubMed Web of Science ®Google Scholar
• G.E. Costin and V.J. Hearing, Human skin pigmentation: Melanocytes modulate skin color in response to stress, Faseb J. 21 (2007), pp. 976–994. doi:10.1096/fj.06-6649rev.
   PubMed Web of Science ®Google Scholar
• S.J. Ahn, M. Koketsu, H. Ishihara, S.M. Lee, S.K. Ha, K.H. Lee, T.H. Kang, and S.Y. Kim, Regulation of melanin synthesis by selenium-containing carbohydrates, Chem. Pharm. Bull. 54 (2006), pp. 281–286. doi:10.1248/cpb.54.281.
   PubMed Web of Science ®Google Scholar
• K. Iozumi, G.E. Hoganson, R. Pennella, M.A. Everett, and B.B. Fuller, Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes, J. Invest. Dermatol. 100 (1993), pp. 806–811. doi:10.1111/1523-1747.ep12476630.
   PubMed Web of Science ®Google Scholar
• G. Li, H.K. Ju, H.W. Chang, Y. Jahng, S.H. Lee, and J.K. Son, Melanin biosynthesis inhibitors from the bark of Machilus thunbergii, Biol. Pharm. Bull. 26 (2003), pp. 1039–1041. doi:10.1248/bpb.26.1039.
   PubMed Web of Science ®Google Scholar
• N. Unver, P. Freyschmidt-Paul, S. Horster, H. Wenck, F. Stab, T. Blatt, and H.P. Elsasser, Alterations in the epidermal-dermal melanin axis and factor xiiia melanophages in senile lentigo and ageing skin, Br. J. Dermatol. 155 (2006), pp. 119–128. doi:10.1111/j.1365-2133.2006.07210.x.
   PubMed Web of Science ®Google Scholar
• M. Brenner and V.J. Hearing, The protective role of melanin against uv damage in human skin, Photochem. Photobiol. 84 (2008), pp. 539–549. doi:10.1111/j.1751-1097.2007.00226.x.
   PubMed Web of Science ®Google Scholar
• M. McCarthy, Us melanoma prevalence has doubled over past 30 years, BMJ-Brit. Med. J. 350 (2015), pp. h3074. doi:10.1136/bmj.h3074.
   Web of Science ®Google Scholar
• C.E. DeSantis, C.C. Lin, A.B. Mariotto, R.L. Siegel, K.D. Stein, J.L. Kramer, R. Alteri, A.S. Robbins, and A. Jemal, Cancer treatment and survivorship statistics, 2014, Ca-Cancer. J. Clin. 64 (2014), pp. 252–271. doi:10.3322/caac.21235.
   PubMed Web of Science ®Google Scholar
• J.L. Boyle, H.M. Haupt, J.B. Stern, and H.A.B. Mulhaupt, Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors: An immunohistochemical study, Arch. Pathol. Lab. Med. 126 (2002), pp. 816–822. doi:10.1043/0003-9985(2002)126.
   PubMed Web of Science ®Google Scholar
• C. Altaner, Prodrug cancer gene therapy, Cancer. Lett. 270 (2008), pp. 191–201. doi:10.1016/j.canlet.2008.04.023.
   PubMed Web of Science ®Google Scholar
• E.L. Cavalieri, K.M. Li, N. Balu, M. Saeed, P. Devanesan, S. Higginbotham, J. Zhao, M.L. Gross, and E.G. Rogan, Catechol ortho-quinones: The electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases, Carcinogenesis 23 (2002), pp. 1071–1077. doi:10.1093/carcin/23.6.1071.
   PubMed Web of Science ®Google Scholar
• T. Hasegawa, Tyrosinase-expressing neuronal cell line as in vitro model of parkinson’s disease, Int. J. Mol. Sci. 11 (2010), pp. 1082–1089. doi:10.3390/ijms11031082.
   PubMed Web of Science ®Google Scholar
• I. Tessari, M. Bisaglia, F. Valle, B. Samori, E. Bergantino, S. Mammi, and L. Bubacco, The reaction of alpha-synuclein with tyrosinase: Possible implications for parkinson disease, J. Biol. Chem. 283 (2008), pp. 16808–16817. doi:10.1074/jbc.M709014200.
   PubMed Web of Science ®Google Scholar
• E. Greggio, E. Bergantino, D. Carter, R. Ahmad, G.-E. Costin, V.J. Hearing, J. Clarimon, A. Singleton, J. Eerola, O. Hellström, P.J. Tienari, D.W. Miller, A. Beilina, L. Bubacco, and M.R. Cookson, Tyrosinase exacerbates dopamine toxicity but is not genetically associated with parkinson’s disease, J. Neurochem. 93 (2005), pp. 246–256. doi:10.1111/j.1471-4159.2005.03019.x.
   PubMed Web of Science ®Google Scholar
• T. Pillaiyar, M. Manickam, and V. Namasivayam, Skin whitening agents: Medicinal chemistry perspective of tyrosinase inhibitors, J. Enzym. Inhib. Med. Chem. 32 (2017), pp. 403–425. doi:10.1080/14756366.2016.1256882.
   PubMed Web of Science ®Google Scholar
• S. Zolghadri, A. Bahrami, M.T.H. Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas, and A.A. Saboury, A comprehensive review on tyrosinase inhibitors, J. Enzym. Inhib. Med. Chem. 34 (2019), pp. 279–309. doi:10.1080/14756366.2018.1545767.
   PubMed Web of Science ®Google Scholar
• Y.S. Lee, J.H. Park, M.H. Kim, S.H. Seo, and H.J. Kim, Synthesis of tyrosinase inhibitory kojic acid derivative, Arch. Pharm. 339 (2006), pp. 111–114. doi:10.1002/ardp.200500213.
   PubMed Web of Science ®Google Scholar
• K. Sakuma, M. Ogawa, K. Sugibayashi, K. Yamada, and K. Yamamoto, Relationship between tyrosinase inhibitory action and oxidation-reduction potential of cosmetic whitening ingredients and phenol derivatives, Arch. Pharm. Res. 22 (1999), pp. 335–339. doi:10.1007/BF02979054.
   PubMed Web of Science ®Google Scholar
• K. Maeda and M. Fukuda, Arbutin: Mechanism of its depigmenting action in human melanocyte culture, J. Pharmacol. Exp. Ther. 276 (1996), pp. 765–769.
   PubMed Web of Science ®Google Scholar
• K.U. Schallreuter and J.W. Wood, A possible mechanism of action for azelaic acid in the human epidermis, Arch. Dermatol. Res. 282 (1990), pp. 168–171. doi:10.1007/bf00372617.
   PubMed Web of Science ®Google Scholar
• Q.X. Chen, L.N. Ke, K.K. Song, H. Huang, and X.D. Liu, Inhibitory effects of hexylresorcinol and dodecylresorcinol on mushroom (Agaricus bisporus) tyrosinase, Protein J. 23 (2004), pp. 135–141. doi:10.1023/B:JOPC.0000020080.21417.ff.
   PubMed Web of Science ®Google Scholar
• N. Fujimoto, H. Onodera, K. Mitsumori, T. Tamura, S. Maruyama, and A. Ito, Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in f344 rats, Carcinogenesis 20 (1999), pp. 1567–1571. doi:10.1093/carcin/20.8.1567.
   PubMed Web of Science ®Google Scholar
• H. Zhou, J.K. Kepa, D. Siegel, S. Miura, Y. Hiraki, and D. Ross, Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells, Mol. Pharmacol. 76 (2009), pp. 579–587. doi:10.1124/mol.109.057323.
   PubMed Web of Science ®Google Scholar
• V. Spinola, B. Mendes, J.S. Camara, and P.C. Castilho, Effect of time and temperature on vitamin c stability in horticultural extracts. Uhplc-pda vs iodometric titration as analytical methods, Lwt-Food Sci. Technol. 50 (2013), pp. 489–495. doi:10.1016/j.lwt.2012.08.020.
   Web of Science ®Google Scholar
• S.J.Y. Macalino, V. Gosu, S.H. Hong, and S. Choi, Role of computer-aided drug design in modern drug discovery, Arch. Pharm. Res. 38 (2015), pp. 1686–1701. doi:10.1007/s12272-015-0640-5.
   PubMed Web of Science ®Google Scholar
• Y. Xi, Z. Qin, and A. Yan, SAR and QSAR models of cyclooxygenase-1 (cox-1) inhibitors, SAR QSAR Environ. Res. 29 (2018), pp. 755–784. doi:10.1080/1062936x.2018.1513952.
   PubMed Web of Science ®Google Scholar
• Z. Qin and A. Yan, QSAR studies on hepatitis c virus ns5a protein tetracyclic inhibitors in wild type and mutants by CoMFA and CoMSIA, SAR QSAR Environ. Res. 31 (2020), pp. 281–311. doi:10.1080/1062936x.2020.1740889.
   PubMed Web of Science ®Google Scholar
• B. De, I. Adhikari, A. Nandy, A. Saha, and B.B. Goswami, In silico modelling of azole derivatives with tyrosinase inhibition ability: Application of the models for activity prediction of new compounds, Comput. Biol. Chem. 74 (2018), pp. 105–114. doi:10.1016/j.compbiolchem.2018.03.007.
   PubMed Web of Science ®Google Scholar
• S. Ghayas, M.A. Masood, R. Parveen, M. Aquib, M.A. Farooq, P. Banerjee, S. Sambhare, and R. Bavi, 3D QSAR pharmacophore-based virtual screening for the identification of potential inhibitors of tyrosinase, J. Biomol. Struct. Dyn. 38 (2020), pp. 2916–2927. doi:10.1080/07391102.2019.1647287.
   PubMed Web of Science ®Google Scholar
• H.H. Dong, J. Liu, X.R. Liu, Y.Y. Yu, and S.W. Cao, Molecular docking and QSAR analyses of aromatic heterocycle thiosemicarbazone analogues for finding novel tyrosinase inhibitors, Bioorg. Chem. 75 (2017), pp. 106–117. doi:10.1016/j.bioorg.2017.07.002
   PubMed Web of Science ®Google Scholar
• Z.X. Zhou, J.R. Zhuo, S.J. Yan, and L. Ma, Design and synthesis of 3,5-diaryl-4,5-dihydro-1h-pyrazoles as new tyrosinase inhibitors, Bioorg. Med. Chem. 21 (2013), pp. 2156–2162. doi:10.1016/j.bmc.2012.12.054
   PubMed Web of Science ®Google Scholar
• Z.H. Zhang, J.B. Liu, F.Y. Wu, and L.Z. Zhao, Inhibitory effects of substituted cinnamic acid esters on mushroom tyrosinase, Lett. Drug Des. Discov. 10 (2013), pp. 529–534. doi:10.2174/1570180811310060009
   Web of Science ®Google Scholar
• A. You, J. Zhou, S.C. Song, G.X. Zhu, H.C. Song, and W. Yi, Rational design, synthesis and structure-activity relationships of 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues as novel tyrosinase inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 924–931. doi:10.1016/j.bmc.2015.01.024
   PubMed Web of Science ®Google Scholar
• A. You, J. Zhou, S.C. Song, G.X. Zhu, H.C. Song, and W. Yi, Structure-based modification of 3-/4-aminoacetophenones giving a profound change of activity on tyrosinase: From potent activators to highly efficient inhibitors, Eur. J. Med. Chem. 93 (2015), pp. 255–262. doi:10.1016/j.ejmech.2015.02.013
   PubMed Web of Science ®Google Scholar
• W. Yi, C. Dubois, S. Yahiaoui, R. Haudecoeur, C. Belle, H.C. Song, R. Hardre, M. Reglier, and A. Boumendjel, Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase, Eur. J. Med. Chem. 46 (2011), pp. 4330–4335. doi:10.1016/j.ejmech.2011.07.003
   PubMed Web of Science ®Google Scholar
• Q. Yan, R.H. Cao, W. Yi, Z.Y. Chen, H. Wen, L. Ma, and H.C. Song, Inhibitory effects of 5-benzylidene barbiturate derivatives on mushroom tyrosinase and their antibacterial activities, Eur. J. Med. Chem. 44 (2009), pp. 4235–4243. doi:10.1016/j.ejmech.2009.05.023
   PubMed Web of Science ®Google Scholar
• J. Xu, J. Liu, X.Q. Zhu, Y.Y. Yu, and S.W. Cao, Novel inhibitors of tyrosinase produced by the 4-substitution of tct, Food Chem. 221 (2017), pp. 1530–1538. doi:10.1016/j.foodchem.2016.10.140
   PubMed Web of Science ®Google Scholar
• W.L. Xie, H.L. Zhang, J.J. He, J.G. Zhang, Q.Y. Yu, C.X. Luo, and S.R. Li, Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase, Bioorg. Med. Chem. Lett. 27 (2017), pp. 530–532. doi:10.1016/j.bmcl.2016.12.027
   PubMed Web of Science ®Google Scholar
• J.L. Wu, X.S. Hu, and L. Ma, Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors, J. Enzym. Inhib. Med. Chem. 26 (2011), pp. 449–452. doi:10.3109/14756366.2010.521745
   PubMed Web of Science ®Google Scholar
• Y. Wang, L.Y. Xu, X. Liu, X.R. He, G. Ren, L.H. Feng, and Z.W. Zhou, Artopithecins A–D, prenylated 2-Arylbenzofurans from the twigs of Artocarpus pithecogallus and their tyrosinase inhibitory activities, Chem. Pharm. Bull. 66 (2018), pp. 1199–1202. doi:10.1248/cpb.c18-00523
   PubMed Web of Science ®Google Scholar
• Y. Wang, M.J. Curtis-Long, B.W. Lee, H.J. Yuk, D.W. Kim, X.F. Tan, and K.H. Park, Inhibition of tyrosinase activity by polyphenol compounds from Flemingia philippinensis roots, Bioorg. Med. Chem. 22 (2014), pp. 1115–1120. doi:10.1016/j.bmc.2013.12.047
   PubMed Web of Science ®Google Scholar
• A. Vontzalidou, G. Zoidis, E. Chaita, M. Makropoulou, N. Aligiannis, G. Lambrinidis, E. Mikros, and A.L. Skaltsounis, Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 22 (2012), pp. 5523–5526. doi:10.1016/j.bmcl.2012.07.029
   PubMed Web of Science ®Google Scholar
• X. Tan, Y.H. Song, C. Park, K.W. Lee, J.Y. Kim, D.W. Kim, K.D. Kim, K.W. Lee, M.J. Curtis-Long, and K.H. Park, Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking, Bioorg. Med. Chem. 24 (2016), pp. 153–159. doi:10.1016/j.bmc.2015.11.040
   PubMed Web of Science ®Google Scholar
• S.C. Song, A. You, Z.Y. Chen, G.X. Zhu, H. Wen, H.C. Song, and W. Yi, Study on the design, synthesis and structure-activity relationships of new thiosemicarbazone compounds as tyrosinase inhibitors, Eur. J. Med. Chem. 139 (2017), pp. 815–825. doi:10.1016/j.ejmech.2017.08.033
   PubMed Web of Science ®Google Scholar
• Z.J. Sheng, S.Y. Ge, X.M. Xu, Y. Zhang, P.P. Wu, K. Zhang, X.T. Xu, C. Li, D.G. Zhao, and X.W. Tang, Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors, MedChemComm 9 (2018), pp. 853–861. doi:10.1039/c8md00099a
   PubMed Web of Science ®Google Scholar
• A. Setyawati, K. Hirabayashi, K. Yamauchi, H. Hattori, T. Mitsunaga, I. Batubara, R. Heryanto, H. Hashimoto, and M. Hotta, Melanogenesis inhibitory activity of components from salam leaf (Syzygium polyanthum) extract, J. Nat. Med. 72 (2018), pp. 474–480. doi:10.1007/s11418-018-1171-4
   PubMed Web of Science ®Google Scholar
• M.D. Santi, M.A. Peralta, M. Puiatti, J.L. Cabrera, and M.G. Ortega, Melanogenic inhibitory effects of triangularin in b16f0 melanoma cells, in vitro and molecular docking studies, Bioorg. Med. Chem. 27 (2019), pp. 3722–3728. doi:10.1016/j.bmc.2019.06.041
   PubMed Web of Science ®Google Scholar
• T. Sabudak, O. Demirkiran, M. Ozturk, and G. Topcu, Phenolic compounds from Trifolium echinatum bieb. and investigation of their tyrosinase inhibitory and antioxidant activities, Phytochemistry 96 (2013), pp. 305–311. doi:10.1016/j.phytochem.2013.08.014
   PubMed Web of Science ®Google Scholar
• J.S. Roh, J.Y. Han, J.H. Kim, and J.K. Hwang, Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius l.) seeds for melanogenesis, Biol. Pharma. Bull. 27 (2004), pp. 1976–1978. doi:10.1248/bpb.27.1976
   PubMed Web of Science ®Google Scholar
• M. Rezaei, H.T. Mohammadi, A. Mahdavi, M. Shourian, and H. Ghafouri, Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors, Int. J. Biol. Macromol. 108 (2018), pp. 205–213. doi:10.1016/j.ijbiomac.2017.11.147
   PubMed Web of Science ®Google Scholar
• M. Rafiq, M. Saleem, M. Hanif, S.K. Kang, S.Y. Seo, and K.H. Lee, Synthesis, structural elucidation and bioevaluation of 4-amino-1,2,4-triazole-3-thione’s schiff base derivatives, Arch. Pharm. Res. 39 (2016), pp. 161–171. doi:10.1007/s12272-015-0688-2
   PubMed Web of Science ®Google Scholar
• S.K. Radhakrishnan, R.G. Shimmon, C. Conn, and A.T. Baker, Evaluation of novel chalcone oximes as inhibitors of tyrosinase and melanin formation in b16 cells, Arch. Pharm. 349 (2016), pp. 20–29. doi:10.1002/ardp.201500298
   PubMed Web of Science ®Google Scholar
• S. Radhakrishnan, R. Shimmon, C. Conn, and A. Baker, Inhibitory kinetics of novel 2,3-dihydro-1h-inden-1-one chalcone-like derivatives on mushroom tyrosinase, Bioorg. Med. Chem. Lett. 25 (2015), pp. 5495–5499. doi:10.1016/j.bmcl.2015.10.071
   PubMed Web of Science ®Google Scholar
• S. Radhakrishnan, R. Shimmon, C. Conn, and A. Baker, Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 25 (2015), pp. 4085–4091. doi:10.1016/j.bmcl.2015.08.033
   PubMed Web of Science ®Google Scholar
• R. Qamar, A. Saeed, F.A. Larik, Q. Abbas, M. Hassan, H. Raza, and S.Y. Seo, Novel 1,3-oxazine-tetrazole hybrids as mushroom tyrosinase inhibitors and free radical scavengers: Synthesis, kinetic mechanism, and molecular docking studies, Chem. Biol. Drug Des. 93 (2019), pp. 123–131. doi:10.1111/cbdd.13352
   PubMed Web of Science ®Google Scholar
• F. Pintus, M.J. Matos, S. Vilar, G. Hripcsak, C. Varela, E. Uriarte, L. Santana, F. Borges, R. Medda, A. Di Petrillo, B. Era, and A. Fais, New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies, Bioorg. Med. Chem. 25 (2017), pp. 1687–1695. doi:10.1016/j.bmc.2017.01.037
   PubMed Web of Science ®Google Scholar
• P. Paudel, A. Wagle, S.H. Seong, H.J. Park, H.A. Jung, and J.S. Choi, A new tyrosinase inhibitor from the red alga Symphyocladia latiuscula (harvey) yamada (rhodomelaceae), Mar. Drugs. 17 (2019), pp. 14. doi:10.3390/md17050295
   Web of Science ®Google Scholar
• Z.Z. Pan, H.L. Li, X.J. Yu, Q.X. Zuo, G.X. Zheng, Y. Shi, X. Liu, Y.M. Lin, G. Liang, Q. Wang, and Q.X. Chen, Synthesis and antityrosinase activities of alkyl 3,4-dihydroxybenzoates, J. Agric. Food Chem. 59 (2011), pp. 6645–6649. doi:10.1021/jf200990g
   PubMed Web of Science ®Google Scholar
• S. Okajima, A. Hamamoto, M. Asano, K. Isogawa, H. Ito, S. Kato, Y. Hirata, K. Furuta, and H. Takemori, Azepine derivative t4fat, a new copper chelator, inhibits tyrosinase, Biochem. Biophys. Res. Commun. 509 (2019), pp. 209–215. doi:10.1016/j.bbrc.2018.12.105
   PubMed Web of Science ®Google Scholar
• K. Nihei and I. Kubo, Benzonitriles as tyrosinase inhibitors with hyperbolic inhibition manner, Int. J. Biol. Macromol. 133 (2019), pp. 929–932. doi:10.1016/j.ijbiomac.2019.04.156
   PubMed Web of Science ®Google Scholar
• S. Mutahir, M.A. Khan, I.U. Khan, M. Yar, M. Ashraf, S. Tariq, R.L. Ye, and B.J. Zhou, Organocatalyzed and mechanochemical solvent-free synthesis of novel and functionalized bis-biphenyl substituted thiazolidinones as potent tyrosinase inhibitors: SAR and molecular modeling studies, Eur. J. Med. Chem. 134 (2017), pp. 406–414. doi:10.1016/j.ejmech.2017.04.021
   PubMed Web of Science ®Google Scholar
• M.N. Mustafa, A. Saeed, P.A. Channar, F.A. Larik, M. Zain-ul Abideen, G. Shabir, Q. Abbas, M. Hassan, H. Raza, and S.Y. Seo, Synthesis, molecular docking and kinetic studies of novel quinolinyl based acyl thioureas as mushroom tyrosinase inhibitors and free radical scavengers, Bioorg. Chem. 90 (2019), pp. 103063. doi:10.1016/j.bioorg.2019.103063
   PubMed Web of Science ®Google Scholar
• R. Micillo, J. Sires-Campos, J.C. Garcia-Borron, L. Panzella, A. Napolitano, and C. Olivares, Conjugation with dihydrolipoic acid imparts caffeic acid ester potent inhibitory effect on dopa oxidase activity of human tyrosinase, Int. J. Mol. Sci. 19 (2018), pp. 2156. doi:10.3390/ijms19082156
   Web of Science ®Google Scholar
• H. Matsuda, S. Nakashima, Y. Oda, S. Nakamura, and M. Yoshikawa, Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in b16 melanoma cells, Bioorg. Med. Chem. 17 (2009), pp. 6048–6053. doi:10.1016/j.bmc.2009.06.057
   PubMed Web of Science ®Google Scholar
• Y. Masamoto, Y. Murata, K. Baba, Y. Shimoishi, M. Tada, and K. Takahata, Inhibitory effects of esculetin on melanin biosynthesis, Biol. Pharma. Bull. 27 (2004), pp. 422–425. doi:10.1248/bpb.27.422
   PubMed Web of Science ®Google Scholar
• Y. Masamoto, H. Ando, Y. Murata, Y. Shimoishi, M. Tada, and K. Takahata, Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L., Biosci. Biotechnol. Biochem. 67 (2003), pp. 631–634. doi:10.1271/bbb.67.631
   PubMed Web of Science ®Google Scholar
• M. Mahdavi, A. Ashtari, M. Khoshneviszadeh, S. Ranjbar, A. Dehghani, T. Akbarzadeh, B. Larijani, M. Khoshneviszadeh, and M. Saeedi, Synthesis of new benzimidazole-1,2,3-triazole hybrids as tyrosinase inhibitors, Chem. Biodivers. 15 (2018), pp. e1800120. doi:10.1002/cbdv.201800120
   PubMed Web of Science ®Google Scholar
• P.P. Liu, C. Shu, L.J. Liu, Q.C. Huang, and Y.Q. Peng, Design and synthesis of thiourea derivatives with sulfur-containing heterocyclic scaffolds as potential tyrosinase inhibitors, Bioorg. Med. Chem. 24 (2016), pp. 1866–1871. doi:10.1016/j.bmc.2016.03.013
   PubMed Web of Science ®Google Scholar
• J.B. Liu, F.Y. Wu, L.J. Chen, J.M. Hu, L.Z. Zhao, C.H. Chen, and L.W. Peng, Evaluation of dihydropyrimidin-(2h)-one analogues and rhodanine derivatives as tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 21 (2011), pp. 2376–2379. doi:10.1016/j.bmcl.2011.02.076
   PubMed Web of Science ®Google Scholar
• J.B. Liu, F.Y. Wu, and C.H. Chen, Design and synthesis of aloe-emodin derivatives as potent anti-tyrosinase, antibacterial and anti-inflammatory agents, Bioorg. Med. Chem. Lett. 25 (2015), pp. 5142–5146. doi:10.1016/j.bmcl.2015.10.004
   PubMed Web of Science ®Google Scholar
• J.B. Liu, C.H. Chen, F.Y. Wu, and L.Z. Zhao, Microwave-assisted synthesis and tyrosinase inhibitory activity of chalcone derivatives, Chem. Biol. Drug Des. 82 (2013), pp. 39–47. doi:10.1111/cbdd.12126
   PubMed Web of Science ®Google Scholar
• J.B. Liu, R.H. Cao, W. Yi, C.M. Ma, Y.Q. Wan, B.H. Zhou, L. Ma, and H.C. Song, A class of potent tyrosinase inhibitors: Alkylidenethiosemicarbazide compounds, Eur. J. Med. Chem. 44 (2009), pp. 1773–1778. doi:10.1016/j.ejmech.2008.04.002
   PubMed Web of Science ®Google Scholar
• J. Liu, W. Yi, Y. Wan, L. Ma, and H. Song, 1-(1-arylethylidene)thiosemicarbazide derivatives: A new class of tyrosinase inhibitors, Bioorg. Med. Chem. 16 (2008), pp. 1096–1102. doi:10.1016/j.bmc.2007.10.102
   PubMed Web of Science ®Google Scholar
• K. Likhitwitayawuid, A. Sornsute, B. Sritularak, and P. Ploypradith, Chemical transformations of oxyresveratrol (trans-2,4,3,5-tetrahydroxystilbene) into a potent tyrosinase inhibitor and a strong cytotoxic agent, Bioorg. Med. Chem. Lett. 16 (2006), pp. 5650–5653. doi:10.1016/j.bmcl.2006.08.018
   PubMed Web of Science ®Google Scholar
• J.L. Liang, U. Javed, S.H. Lee, J.G. Park, and Y. Jahng, Synthesis of 6-deoxymollugins and their inhibitory activities on tyrosinase, Arch. Pharm. Res. 37 (2014), pp. 862–872. doi:10.1007/s12272-013-0240-1
   PubMed Web of Science ®Google Scholar
• J.P. Ley and H.J. Bertram, Hydroxy- or methoxy-substituted benzaldoximes and benzaldehyde-o-alkyloximes as tyrosinase inhibitors, Bioorg. Med. Chem. 9 (2001), pp. 1879–1885. doi:10.1016/s0968-0896(01)00084-0
   PubMed Web of Science ®Google Scholar
• K.H. Lee, M. Koketsu, S.Y. Choi, K.J. Lee, P. Lee, H. Ishihara, and S.Y. Kim, Potent inhibitory effects of n-aryl s-alkylthiocarbamate derivatives on the dopa oxidase activity of mushroom tyrosinase, Chem. Pharm. Bull. 53 (2005), pp. 747–749. doi:10.1248/cpb.53.747
   PubMed Web of Science ®Google Scholar
• F.A. Larik, A. Saeed, P.A. Channar, U. Muqadar, Q. Abbas, M. Hassan, S.Y. Seo, and M. Bolte, Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers, Eur. J. Med. Chem. 141 (2017), pp. 273–281. doi:10.1016/j.ejmech.2017.09.059
   PubMed Web of Science ®Google Scholar
• K.W. Lam, A. Syahida, Z. Ul-Haq, M.B.A. Rahman, and N.H. Lajis, Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 20 (2010), pp. 3755–3759. doi:10.1016/j.bmcl.2010.04.067
   PubMed Web of Science ®Google Scholar
• S.Y. Kwak, J.K. Yang, H.R. Choi, K.C. Park, Y.B. Kim, and Y.S. Lee, Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl/prolyl hydroxamic acid derivatives as tyrosinase inhibitor and antioxidant, Bioorg. Med. Chem. Lett. 23 (2013), pp. 1136–1142. doi:10.1016/j.bmcl.2012.10.107
   PubMed Web of Science ®Google Scholar
• Y. Komori, M. Imai, T. Yamauchi, K. Higashiyama, and N. Takahashi, Effect of p-aminophenols on tyrosinase activity, Bioorg. Med. Chem. 22 (2014), pp. 3994–4000. doi:10.1016/j.bmc.2014.05.073
   PubMed Web of Science ®Google Scholar
• K.D. Kim, M.H. Song, E.K. Yum, O.S. Jeon, Y.W. Ju, and M.S. Chang, Melanogenesis inhibition by mono-hydroxycinnamic ester derivatives in b16 melanoma cells, Bull. Korean Chem. Soc. 31 (2010), pp. 181–184. doi:10.5012/bkcs.2010.31.01.181
   Web of Science ®Google Scholar
• K.D. Kim, M.H. Song, E.K. Yum, O.S. Jeon, Y.W. Ju, and M.S. Chang, 2,4-dihydroxycinnamic esters as skin depigmenting agents, Bull. Korean Chem. Soc. 30 (2009), pp. 1619–1621. doi:10.5012/bkcs.2009.30.7.1619
   Web of Science ®Google Scholar
• D.W. Kim, H.S. Woo, J.Y. Kim, J.A. Ryuk, K.H. Park, and B.S. Ko, Phenols displaying tyrosinase inhibition from Humulus lupulus, J. Enzym. Inhib. Med. Chem. 31 (2016), pp. 742–747. doi:10.3109/14756366.2015.1063621
   PubMed Web of Science ®Google Scholar
• S. Khatib, O. Nerya, R. Musa, M. Shmuel, S. Tamir, and J. Vaya, Chalcones as potent tyrosinase inhibitors: The importance of a 2,4-substituted resorcinol moiety, Bioorg. Med. Chem. 13 (2005), pp. 433–441. doi:10.1016/j.bmc.2004.10.010
   PubMed Web of Science ®Google Scholar
• M.T.H. Khan, M.I. Choudhary, K.M. Khan, M. Rani, and R. Attaur, Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues, Bioorg. Med. Chem. 13 (2005), pp. 3385–3395. doi:10.1016/j.bmc.2005.03.012
   PubMed Web of Science ®Google Scholar
• K.M. Khan, U.R. Mughal, M.T.H. Khan, U. Zia, S. Perveen, and M.I. Choudhary, Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships, Bioorg. Med. Chem. 14 (2006), pp. 6027–6033. doi:10.1016/j.bmc.2006.05.014
   PubMed Web of Science ®Google Scholar
• K.M. Khan, G.M. Maharvi, M.T.H. Khan, A.J. Shaikh, S. Perveen, S. Begum, and M.I. Choudhary, Tetraketones: A new class of tyrosinase inhibitors, Bioorg. Med. Chem. 14 (2006), pp. 344–351. doi:10.1016/j.bmc.2005.08.029
   PubMed Web of Science ®Google Scholar
• G. Karakaya, A. Ture, A. Ercan, S. Oncul, and M.D. Aytemir, Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives, Bioorg. Chem. 88 (2019), pp. 102950. doi:10.1016/j.bioorg.2019.102950
   PubMed Web of Science ®Google Scholar
• H. Kamauchi, M. Noji, K. Kinoshita, T. Takanami, and K. Koyama, Coumarins with an unprecedented tetracyclic skeleton and coumarin dimers from chemically engineered extracts of a marine-derived fungus, Tetrahedron. 74 (2018), pp. 2846–2856. doi:10.1016/j.tet.2018.04.033
   Web of Science ®Google Scholar
• J.A. Jacobsen, J.L. Fullagar, M.T. Miller, and S.M. Cohen, Identifying chelators for metalloprotein inhibitors using a fragment-based approach, J. Med. Chem. 54 (2011), pp. 591–602. doi:10.1021/jm101266s
   PubMed Web of Science ®Google Scholar
• H. Hamidian, R. Tagizadeh, S. Fozooni, V. Abbasalipour, A. Taheri, and M. Namjou, Synthesis of novel azo compounds containing 5(4h)-oxazolone ring as potent tyrosinase inhibitors, Bioorg. Med. Chem. 21 (2013), pp. 2088–2092. doi:10.1016/j.bmc.2013.01.014
   PubMed Web of Science ®Google Scholar
• H. Hamidian and S. Azizi, Synthesis of novel compounds containing morpholine and 5(4h)-oxazolone rings as potent tyrosinase inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 7089–7094. doi:10.1016/j.bmc.2015.09.015
   PubMed Web of Science ®Google Scholar
• Z.T. Gur, F.S. Senol, S. Shekfeh, I.E. Orhan, E. Banoglu, and B. Caliskan, Novel piperazine amides of cinnamic acid derivatives as tyrosinase inhibitors, Lett. Drug. Des. Discov. 16 (2019), pp. 36–44. doi:10.2174/1570180815666180420105652
   Web of Science ®Google Scholar
• S. Ghafary, S. Ranjbar, B. Larijani, M. Amini, M. Biglar, M. Mahdavi, M. Bakhshaei, M. Khoshneviszadeh, A. Sakhteman, and M. Khoshneviszadeh, Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors, Int. J. Biol. Macromol. 135 (2019), pp. 978–985. doi:10.1016/j.ijbiomac.2019.05.201
   PubMed Web of Science ®Google Scholar
• S.S. Gawande, S.C. Warangkar, B.P. Bandgar, and C.N. Khobragade, Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase, Bioorg. Med. Chem. 21 (2013), pp. 2772–2777. doi:10.1016/j.bmc.2012.12.053
   PubMed Web of Science ®Google Scholar
• A. Garcia-Jimenez, J.A. Teruel-Puche, J. Berna, J.N. Rodriguez-Lopez, J. Tudela, P.A. Garcia-Ruiz, and F. Garcia-Canovas, Characterization of the action of tyrosinase on resorcinols, Bioorg. Med. Chem. 24 (2016), pp. 4434–4443. doi:10.1016/j.bmc.2016.07.048
   PubMed Web of Science ®Google Scholar
• H. Gao, J. Nishida, S. Saito, and J. Kawabata, Inhibitory effects of 5,6,7-trihydroxyflavones on tyrosinase, Molecules 12 (2007), pp. 86–97. doi:10.3390/12010086
   PubMed Web of Science ®Google Scholar
• K.A. Ford, A.G. Gulevich, T.L. Swenson, and J.E. Casida, Neonicotinoid insecticides: Oxidative stress in planta and metallo-oxidase inhibition, J. Agric. Food Chem. 59 (2011), pp. 4860–4867. doi:10.1021/jf200485k
   PubMed Web of Science ®Google Scholar
• S. Ferro, B. Deri, M.P. Germano, R. Gitto, L. Ielo, M.R. Buemi, G. Certo, S. Vittorio, A. Rapisarda, Y. Pazy, A. Fishman, and L. De Luca, Targeting tyrosinase: Development and structural insights of novel inhibitors bearing arylpiperidine and arylpiperazine fragments, J. Med. Chem. 61 (2018), pp. 3908–3917. doi:10.1021/acs.jmedchem.7b01745
   PubMed Web of Science ®Google Scholar
• S. Ferro, G. Certo, L. De Luca, M.P. Germano, A. Rapisarda, and R. Gitto, Searching for indole derivatives as potential mushroom tyrosinase inhibitors, J. Enzym. Inhib. Med. Chem. 31 (2016), pp. 398–403. doi:10.3109/14756366.2015.1029470
   PubMed Web of Science ®Google Scholar
• Y.T. Fang, Y.Z. Chen, G.F. Feng, and L. Ma, Benzyl benzoates: New phlorizin analogs as mushroom tyrosinase inhibitors, Bioorg. Med. Chem. 19 (2011), pp. 1167–1171. doi:10.1016/j.bmc.2010.12.051
   PubMed Web of Science ®Google Scholar
• Q. Fan, H. Jiang, E.D. Yuan, J.X. Zhang, Z.X. Ning, S.J. Qi, and Q.Y. Wei, Tyrosinase inhibitory effects and antioxidative activities of novel cinnamoyl amides with amino acid ester moiety, Food Chem. 134 (2012), pp. 1081–1087. doi:10.1016/j.foodchem.2012.03.021
   PubMed Web of Science ®Google Scholar
• J.J. Faig, A. Moretti, L.B. Joseph, Y.Y. Zhang, M.J. Nova, K. Smith, and K.E. Uhrich, Biodegradable kojic acid-based polymers: Controlled delivery of bioactives for melanogenesis inhibition, Biomacromolecules 18 (2017), pp. 363–373. doi:10.1021/acs.biomac.6b01353
   PubMed Web of Science ®Google Scholar
• Z.Y. Du, Y.F. Jiang, Z.K. Tang, R.Q. Mo, G.H. Xue, Y.J. Lu, X. Zheng, C.Z. Dong, and K. Zhang, Antioxidation and tyrosinase inhibition of polyphenolic curcumin analogs, Biosci. Biotechnol. Biochem. 75 (2011), pp. 2351–2358. doi:10.1271/bbb.110547
   PubMed Web of Science ®Google Scholar
• G. Delogu, G. Podda, M. Corda, M.B. Fadda, A. Fais, and B. Era, Synthesis and biological evaluation of a novel series of bis-salicylaldehydes as mushroom tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 20 (2010), pp. 6138–6140. doi:10.1016/j.bmcl.2010.08.018
   PubMed Web of Science ®Google Scholar
• Z. Dehghani, M. Khoshneviszadeh, M. Khoshneviszadeh, and S. Ranjbar, Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers, Bioorg. Med. Chem. 27 (2019), pp. 2644–2651. doi:10.1016/j.bmc.2019.04.016
   PubMed Web of Science ®Google Scholar
• Y. Cui, Y.H. Hu, F. Yu, J. Zheng, L.S. Chen, Q.X. Chen, and Q. Wang, Inhibition kinetics and molecular simulation of p-substituted cinnamic acid derivatives on tyrosinase, Int. J. Biol. Macromol. 95 (2017), pp. 1289–1297. doi:10.1016/j.ijbiomac.2016.11.027
   PubMed Web of Science ®Google Scholar
• M.I. Crespo, M.F. Chaban, P.A. Lanza, M.B. Joray, S.M. Palacios, D.M.A. Vera, and M.C. Carpinella, Inhibitory effects of compounds isolated from Lepechinia meyenii on tyrosinase, Food Chem. Toxicol. 125 (2019), pp. 383–391. doi:10.1016/j.fct.2019.01.019
   PubMed Web of Science ®Google Scholar
• S.Y. Choi, S. Kim, H. Kim, K. Suk, J.S. Hwang, B.G. Lee, A.J. Kim, and S.Y. Kim, (4-methoxy-benzylidene)-(3-methoxy-phenyl)-amine, a nitrogen analog of stilbene as a potent inhibitor of melanin production, Chem. Pharm. Bull. 50 (2002), pp. 450–452. doi:10.1248/cpb.50.450
   PubMed Web of Science ®Google Scholar
• S.J. Cho, J.S. Roh, W.S. Sun, S.H. Kim, and K.D. Park, N-benzylbenzamides: A new class of potent tyrosinase inhibitors, Bioorg. Med. Chem. Lett. 16 (2006), pp. 2682–2684. doi:10.1016/j.bmcl.2006.02.018
   PubMed Web of Science ®Google Scholar
• J.C. Cho, H.S. Rho, Y.H. Joo, C.S. Lee, J. Lee, S.M. Ahn, J.E. Kim, S.S. Shin, Y.H. Park, K.D. Suh, and S.N. Park, Depigmenting activities of kojic acid derivatives without tyrosinase inhibitory activities, Bioorg. Med. Chem. Lett. 22 (2012), pp. 4159–4162. doi:10.1016/j.bmcl.2012.04.046
   PubMed Web of Science ®Google Scholar
• M.E. Chiari, D.M.A. Vera, S.M. Palacios, and M.C. Carpinella, Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from dalea elegans, Bioorg. Med. Chem. 19 (2011), pp. 3474–3482. doi:10.1016/j.bmc.2011.04.025
   PubMed Web of Science ®Google Scholar
• Z.Y. Chen, D.C. Cai, D.H. Mou, Q. Yan, Y.F. Sun, W.L. Pan, Y.Q. Wan, H.C. Song, and W. Yi, Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene (thio) barbiturates as novel tyrosinase inhibitors, Bioorg. Med. Chem. 22 (2014), pp. 3279–3284. doi:10.1016/j.bmc.2014.04.060
   PubMed Web of Science ®Google Scholar
• Q.X. Chen and I. Kubo, Kinetics of mushroom tyrosinase inhibition by quercetin, J. Agric. Food Chem. 50 (2002), pp. 4108–4112. doi:10.1021/jf011378z
   PubMed Web of Science ®Google Scholar
• L.H. Chen, Y.H. Hu, W. Song, K.K. Song, X. Liu, Y.L. Jia, J.X. Zhuang, and Q.X. Chen, Synthesis and antityrosinase mechanism of benzaldehyde thiosemicarbazones: Novel tyrosinase inhibitors, J. Agric. Food Chem. 60 (2012), pp. 1542–1547. doi:10.1021/jf204420x
   PubMed Web of Science ®Google Scholar
• P.A. Channar, A. Saeed, F.A. Larik, M. Rafiq, Z. Ashraf, F. Jabeen, and T.A. Fattah, Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl 2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo- thiazolidin-5-ylidene acetates as mushroom tyrosinase inhibitors, Bioorg. Med. Chem. 25 (2017), pp. 5929–5938. doi:10.1016/j.bmc.2017.09.009
   PubMed Web of Science ®Google Scholar
• P.A. Channar, A. Saeed, F.A. Larik, B. Batool, S. Kalsoom, M.M. Hasan, M.F. Erben, H.R. El-Seedi, M. Ali, and Z. Ashraf, Synthesis of aryl pyrazole via suzuki coupling reaction, in vitro mushroom tyrosinase enzyme inhibition assay and in silico comparative molecular docking analysis with kojic acid, Bioorg. Chem. 79 (2018), pp. 293–300. doi:10.1016/j.bioorg.2018.04.026.
   PubMed Web of Science ®Google Scholar
• G.M. Casanola-Martin, Y. Marrero-Ponce, M.T.H. Khan, A. Ather, K.M. Khan, F. Torrens, and R. Rotondo, Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays, Eur. J. Med. Chem. 42 (2007), pp. 1370–1381. doi:10.1016/j.ejmech.2007.01.026.
   PubMed Web of Science ®Google Scholar
• A.R.S. Butt, M.A. Abbasi, R. Azizur, S.Z. Siddiqui, H. Raza, M. Hassan, S.A.A. Shah, M. Shahid, and S.Y. Seo, Synthesis and structure-activity relationship of tyrosinase inhibiting novel bi-heterocyclic acetamides: Mechanistic insights through enzyme inhibition, kinetics and computational studies, Bioorg. Chem. 86 (2019), pp. 459–472. doi:10.1016/j.bioorg.2019.01.036
   PubMed Web of Science ®Google Scholar
• S.N.A. Bukhari, I. Jantan, O.U. Tan, M. Sher, M. Naeem-ul-Hassan, and H.L. Qin, Biological activity and molecular docking studies of curcumin-related alpha,beta-unsaturated carbonyl-based synthetic compounds as anticancer agents and mushroom tyrosinase inhibitors, J. Agric. Food Chem. 62 (2014), pp. 5538–5547. doi:10.1021/jf501145b.
   PubMed Web of Science ®Google Scholar
• B.P. Bandgar, J.V. Totre, S.S. Gawande, C.N. Khobragade, S.C. Warangkar, and P.D. Kadam, Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents, Bioorg. Med. Chem. 18 (2010), pp. 6149–6155. doi:10.1016/j.bmc.2010.06.046.
   PubMed Web of Science ®Google Scholar
• B.P. Bandgar, L.K. Adsul, H.V. Chavan, S.N. Shringare, B.L. Korbad, S.S. Jalde, S.V. Lonikar, S.H. Nile, and A.L. Shirfule, Synthesis, biological evaluation, and molecular docking of n-{3-3-(9-methyl-9h-carbazol-3-yl)-acryloyl -phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors, Bioorg. Med. Chem. 20 (2012), pp. 5649–5657. doi:10.1016/j.bmc.2012.07.001.
   PubMed Web of Science ®Google Scholar
• Y.S. Baek, Y.B. Ryu, M.J. Curtis-Long, T.J. Ha, R. Rengasamy, M.S. Yang, and K.H. Park, Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki, Bioorg. Med. Chem. 17 (2009), pp. 35–41. doi:10.1016/j.bmc.2008.11.022.
   PubMed Web of Science ®Google Scholar
• Z. Ashraf, M. Rafiq, S.Y. Seo, K.S. Kwon, M.M. Babar, and N. Zaidi, Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase, Eur. J. Med. Chem. 98 (2015), pp. 203–211. doi:10.1016/j.ejmech.2015.05.031.
   PubMed Web of Science ®Google Scholar
• Z. Ashraf, M. Rafiq, S.Y. Seo, M.M. Babar, and N. Zaidi, Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase, Bioorg. Med. Chem. 23 (2015), pp. 5870–5880. doi:10.1016/j.bmc.2015.06.068.
   PubMed Web of Science ®Google Scholar
• Z. Ashraf, M. Rafiq, H. Nadeem, M. Hassan, S. Afzal, M. Waseem, K. Afzal, and J. Latip, Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies, PLoS One 12 (2017), pp. e0178069. doi:10.1371/journal.pone.0178069.
   PubMed Web of Science ®Google Scholar
• M. Ashooriha, M. Khoshneviszadeh, M. Khoshneviszadeh, S.E. Moradi, A. Rafiei, M. Kardan, and S. Emami, 1,2,3-triazole-based kojic acid analogs as potent tyrosinase inhibitors: Design, synthesis and biological evaluation, Bioorg. Chem. 82 (2019), pp. 414–422. doi:10.1016/j.bioorg.2018.10.069.
   PubMed Web of Science ®Google Scholar
• E.T. Arung, K. Shimizu, H. Tanaka, and R. Kondo, Melanin biosynthesis inhibitors from wood of Artocarpus heterophyllus: The effect of isoprenoid substituent of flavone with 4-substituted resorcinol moiety at b ring, Lett. Drug Des. Discov. 7 (2010), pp. 602–605. doi:10.2174/157018010792062777.
   Web of Science ®Google Scholar
• E.T. Arung, K. Shimizu, H. Tanaka, and R. Kondo, 3-prenyl luteolin, a new prenylated flavone with melanin biosynthesis inhibitory activity from wood of Artocarpus heterophyllus, Fitoterapia 81 (2010), pp. 640–643. doi:10.1016/j.fitote.2010.03.011.
   PubMed Web of Science ®Google Scholar
• E.T. Arung, K. Shimizu, and R. Kondo, Inhibitory effect of artocarpanone from Artocarpus heterophyllus on melanin biosynthesis, Biol. Pharm. Bull. 29 (2006), pp. 1966–1969. doi:10.1248/bpb.29.1966.
   PubMed Web of Science ®Google Scholar
• V.U. Ahmad, F. Ullah, J. Hussain, U. Farooq, M. Zubair, M.T.H. Khan, and M.I. Choudhary, Tyrosinase inhibitors from Rhododendron collettianum and their structure-activity relationship (SAR) studies, Chem. Pharm. Bull. 52 (2004), pp. 1458–1461. doi:10.1248/cpb.52.1458.
   PubMed Web of Science ®Google Scholar
• S.A. Abdullah, S. Jamil, N. Basar, S.M.A. Lathiff, and N.M. Arriffin, Flavonoids from the leaves and heartwoods of Artocarpus lowii king and their bioactivities, Nat. Prod. Res. 31 (2017), pp. 1113–1120. doi:10.1080/14786419.2016.1222387.
   PubMed Web of Science ®Google Scholar
• Q. Abbas, H. Raza, M. Hassan, A.R. Phull, S.J. Kim, and S.Y. Seo, Acetazolamide inhibits the level of tyrosinase and melanin: An enzyme kinetic, in vitro, in vivo, and in silico studies, Chem. Biodivers. 14 (2017), pp. e1700117. doi:10.1002/cbdv.201700117.
   Web of Science ®Google Scholar
• Q. Abbas, Z. Ashraf, M. Hassan, H. Nadeem, M. Latif, S. Afzal, and S.Y. Seo, Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies, Drug. Des. Dev. Ther. 11 (2017), pp. 2029–2046. doi:10.2147/dddt.S137550
   PubMed Web of Science ®Google Scholar
• R.R.J. Arroo, S. Sari, B. Barut, A. Ozel, K.C. Ruparelia, and D. Sohretoglu, Flavones as tyrosinase inhibitors: Kinetic studies in vitro and in silico, Phytochem. Anal. 31 (2020), pp. 314–321. doi:10.1002/pca.2897.
   PubMed Web of Science ®Google Scholar
• M. Ashooriha, M. Khoshneviszadeh, M. Khoshneviszadeh, A. Rafiei, M. Kardan, R. Yazdian-Robati, and S. Emami, Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors, Eur. J. Med. Chem. 201 (2020), pp. 112480. doi:10.1016/j.ejmech.2020.112480.
   PubMed Web of Science ®Google Scholar
• L. De Luca, M.P. Germano, A. Fais, F. Pintus, M.R. Buemi, S. Vittorio, S. Mirabile, A. Rapisarda, and R. Gitto, Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety, Bioorg. Med. Chem. 28 (2020), pp. 115497. doi:10.1016/j.bmc.2020.115497.
   PubMed Web of Science ®Google Scholar
• K. Haldys, W. Goldeman, M. Jewginski, E. Wolinska, N. Anger-Gora, J. Rossowska, and R. Latajka, Halogenated aromatic thiosemicarbazones as potent inhibitors of tyrosinase and melanogenesis, Bioorg. Chem. 94 (2020), pp. 103419. doi:10.1016/j.bioorg.2019.103419.
   PubMed Web of Science ®Google Scholar
• A. Iraji, T. Adelpour, N. Edraki, M. Khoshneviszadeh, R. Miri, and M. Khoshneviszadeh, Synthesis, biological evaluation and molecular docking analysis of vaniline-benzylidenehydrazine hybrids as potent tyrosinase inhibitors, BMC. Chem. 14 (2020), pp. 1–11. doi:10.1186/s13065-020-00679-1.
   PubMed Web of Science ®Google Scholar
• S. Karimian, S. Ranjbar, M. Dadfar, M. Khoshneviszadeh, M. Gholampour, A. Sakhteman, and M. Khoshneviszadeh, 4h-benzochromene derivatives as novel tyrosinase inhibitors and radical scavengers: Synthesis, biological evaluation, and molecular docking analysis, Mol. Divers. (2020). doi:10.1007/s11030-020-10123-0.
   PubMed Web of Science ®Google Scholar
• J.H. Kim, D.H. Jang, K.W. Lee, K.D. Kim, A.B. Shah, K. Zhumanova, and K.H. Park, Tyrosinase inhibition and kinetic details of puerol a having but-2-enolide structure from Amorpha fruticosa, Molecules 25 (2020), pp. e2344. doi:10.3390/molecules25102344.
   PubMed Web of Science ®Google Scholar
• T.H. Le, T.N.V. Do, H.X. Nguyen, P.H. Dang, N.T. Nguyen, and M.T.T. Nguyen, A new phenylheptanoid from the leaves of Gnetum gnemon l, Nat. Prod. Res. (2020), pp. 1–6. doi:10.1080/14786419.2020.1753055.
   Web of Science ®Google Scholar
• Y. Nazir, A. Saeed, M. Rafiq, S. Afzal, A. Ali, M. Latif, J. Zuegg, W.M. Hussein, C. Fercher, R.T. Barnard, M.A. Cooper, M.A.T. Blaskovich, Z. Ashraf, and Z.M. Ziora, Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies, Bioorg. Med. Chem. Lett. 30 (2020), pp. 126722. doi:10.1016/j.bmcl.2019.126722.
   PubMed Web of Science ®Google Scholar
• L.R. Singh, Y.L. Chen, Y.Y. Xie, W. Xia, X.W. Gong, R.C. Hider, and T. Zhou, Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity, J. Enzym. Inhib. Med. Chem. 35 (2020), pp. 1562–1567. doi:10.1080/14756366.2020.1801669.
   PubMed Web of Science ®Google Scholar
• S.C. Song, Y.L. Mai, H.H. Shi, B. Liao, and F. Wang, Design, synthesis, biological evaluation and inhibition mechanism of 3-/4-alkoxy phenylethylidenethiosemicarbazides as new, potent and safe tyrosinase inhibitors, Chem. Pharm. Bull. 68 (2020), pp. 369–379. doi:10.1248/cpb.c19-00949.
   PubMed Web of Science ®Google Scholar
• X. Song, X. Hu, Y. Zhang, J.H. Pan, D.M. Gong, and G.W. Zhang, Inhibitory mechanism of epicatechin gallate on tyrosinase: Inhibitory interaction, conformational change and computational simulation, Food Funct. 11 (2020), pp. 4892–4902. doi:10.1039/d0fo00003e.
   PubMed Web of Science ®Google Scholar
• B.D. Vanjare, P.G. Mahajan, N.C. Dige, H. Raza, M. Hassan, Y. Han, S.J. Kim, S.Y. Seo, and K.H. Lee, Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: Synthesis, kinetic mechanism, cytotoxicity and computational studies, Mol. Divers. (2020). doi:10.1007/s11030-020-10102-5.
   Web of Science ®Google Scholar
• Y.J. Zhai, G.M. Huo, Q. Zhang, D. Li, D.C. Wang, J.Z. Qi, W.B. Han, and J.M. Gao, Phaeosphaones: Tyrosinase inhibitory thiodiketopiperazines from an endophytic Phaeosphaeria fuckelii, J. Nat. Prod. 83 (2020), pp. 1592–1597. doi:10.1021/acs.jnatprod.0c00046.
   PubMed Web of Science ®Google Scholar
• Y. Zhang, X. Fu, Y.T. Yan, and J.B. Liu, Microwave-assisted synthesis and biological evaluation of new thiazolylhydrazone derivatives as tyrosinase inhibitors and antioxidants, J. Heterocycl. Chem. 57 (2020), pp. 991–1002. doi:10.1002/jhet.3760.
   Web of Science ®Google Scholar
• R. Ujan, A. Saeed, S. Ashraf, P.A. Channar, Q. Abbas, M.A. Rind, M. Hassan, H. Raza, S.Y. Seo, and H.R. El-Seedi, Synthesis, computational studies and enzyme inhibitory kinetics of benzothiazole-linked thioureas as mushroom tyrosinase inhibitors, J. Biomol. Struct. Dyn. (2020), pp. 1–9. doi:10.1080/07391102.2020.1804459.
   PubMed Web of Science ®Google Scholar
• H. Raza, M.A. Abbasi, R. Azizur, S.Z. Siddiqui, M. Hassan, S.A.A. Shah, M. Shahid, H. Hong, and S.Y. Seo, Design, synthesis and computational studies of n-(substituted-phenyl)-4-(4-phenyl-1-piperazinyl)butanamides as potent anti-melanogenic and tyrosinase inhibitors, J. Mol. Struct. 1210 (2020), pp. 127969. doi:10.1016/j.molstruc.2020.127969.
   Web of Science ®Google Scholar
• L. Dinparast, S. Hemmati, A.A. Alizadeh, G. Zengin, H.S. Kafil, M.B. Bahadori, and S. Dastmalchi, An efficient, catalyst-free, one-pot synthesis of 4h-chromene derivatives and investigating their biological activities and mode of interactions using molecular docking studies, J. Mol. Struct. 1203 (2020), pp. 127426. doi:10.1016/j.molstruc.2019.127426.
   Web of Science ®Google Scholar
• G. Casedas, F. Les, C. Choya-Foces, M. Hugo, and V. Lopez, The metabolite urolithin-A ameliorates oxidative stress in Neuro-2a cells, becoming a potential neuroprotective agent, Antioxidants-Basel 9 (2020), pp. 177. doi:10.3390/antiox9020177.
   Web of Science ®Google Scholar
• H. Raza, M.A. Abbasi, R. Azizur, S.Z. Siddiqui, M. Hassan, Q. Abbas, H. Hong, S.A.A. Shah, M. Shahid, and S.Y. Seo, Synthesis, molecular docking, dynamic simulations, kinetic mechanism, cytotoxicity evaluation of n-(substituted-phenyl)-4-{(4- (e)-3-phenyl-2-propenyl −1-piperazinyl} butanamides as tyrosinase and melanin inhibitors: In vitro, in vivo and in silico approaches, Bioorg. Chem. 94 (2020), pp. 103445. doi:10.1016/j.bioorg.2019.103445.
   PubMed Web of Science ®Google Scholar
• J. Xia, S. Li, Y. Ding, S. Wu, and X.S.M. Wang, Mubd-decoymaker 2.0: A Python GUI application to generate maximal unbiased benchmarking data sets for virtual drug screening, Mol. Inf. 39 (2020), pp. e1900151. doi:10.1002/minf.201900151.
   PubMed Web of Science ®Google Scholar
• G.A. Landrum, RDKit 2019.03.4: An open-source cheminformatics software, San Francisco, CA, 2019. accessed October 2020. available at http://www.rdkit.org
   Google Scholar
• S. Riniker and G.A. Landrum, Open-source platform to benchmark fingerprints for ligand-based virtual screening, J. Cheminform. 5 (2013), pp. 1–17. doi:10.1186/1758-2946-5-26.
   PubMed Web of Science ®Google Scholar
• D. Rogers and M. Hahn, Extended-connectivity fingerprints, J. Chem Inf. Model. 50 (2010), pp. 742–754. doi:10.1021/ci100050t.
   PubMed Web of Science ®Google Scholar
• P. Gedeck, B. Rohde, and C. Bartels, QSAR − how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets, J. Chem Inf. Model. 46 (2006), pp. 1924–1936. doi:10.1021/ci050413p.
   PubMed Web of Science ®Google Scholar
• M. Sud, Mayachemtools: An open source package for computational drug discovery, J. Chem. Inf. Model 56 (2016), pp. 2292–2297. doi:10.1021/acs.jcim.6b00505.
   PubMed Web of Science ®Google Scholar
• F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, J. Vanderplas, A. Passos, D. Cournapeau, M. Brucher, M. Perrot, and E. Duchesnay, Scikit-learn: Machine learning in Python, J. Mach. Learn. Res. 12 (2011), pp. 2825–2830.
   Web of Science ®Google Scholar
• I. Guyon, J. Weston, S. Barnhill, and V. Vapnik, Gene selection for cancer classification using support vector machines, Mach. Learn. 46 (2002), pp. 389–422. doi:10.1023/A:1012487302797
   Web of Science ®Google Scholar
• C. Cortes and V. Vapnik, Support-vector networks, Mach. Learn. 20 (1995), pp. 273–297. doi:10.1023/A:1022627411411
   Web of Science ®Google Scholar
• W.Y. Loh, Classification and regression trees, Wires. Data Min. Knowl. 1 (2011), pp. 14–23. doi:10.1002/widm.8
   Web of Science ®Google Scholar
• L. Breiman, Random forests, Mach. Learn. 45 (2001), pp. 5–32. doi:10.1023/a:1010933404324.
   Web of Science ®Google Scholar
• H.F. Yu, F.L. Huang, and C.J. Lin, Dual coordinate descent methods for logistic regression and maximum entropy models, Mach. Learn. 85 (2011), pp. 41–75. doi:10.1007/s10994-010-5221-8.
   Web of Science ®Google Scholar
• Y.T. Xu, J.S. Ma, A. Liaw, R.P. Sheridan, and V. Svetnik, Demystifying multitask deep neural networks for quantitative structure-activity relationships, J. Chem Inf. Model. 57 (2017), pp. 2490–2504. doi:10.1021/acs.jcim.7b00087.
   PubMed Web of Science ®Google Scholar
• Keras 2.2.4: A python deep learning api. Available at https://keras.io (accessed Oct, 2020).
   Google Scholar
• Tensorflow 1.14. accessed October 2020. available at https://tensorflow.google.cn
   Google Scholar
• M. Mete, U. Sakoglu, J.S. Spence, M.D. Devous, T.S. Harris, and B. Adinoff, Successful classification of cocaine dependence using brain imaging: A generalizable machine learning approach, BMC Bioinform. 17 (2016), pp. 357. doi:10.1186/s12859-016-1218-z.
   PubMed Web of Science ®Google Scholar
• L. Prechelt, Automatic early stopping using cross validation: Quantifying the criteria, Neural Netw. 11 (1998), pp. 761–767. doi:10.1016/S0893-6080(98)00010-0.
   PubMed Web of Science ®Google Scholar
• K.J. Preacher, P.J. Curran, and D.J. Bauer, Computational tools for probing interactions in multiple linear regression, multilevel modeling, and latent curve analysis, J. Educ. Behav. Stat. 31 (2006), pp. 437–448. doi:10.3102/10769986031004437
   Web of Science ®Google Scholar
• D. Krstajic, L.J. Buturovic, D.E. Leahy, and S. Thomas, Cross-validation pitfalls when selecting and assessing regression and classification models, J. Cheminf. 6 (2014), pp. 15. doi:10.1186/1758-2946-6-10.
   PubMed Web of Science ®Google Scholar
• I. Sushko, S. Novotarskyi, R. Korner, A.K. Pandey, A. Cherkasov, J.Z. Lo, P. Gramatica, K. Hansen, T. Schroeter, K.R. Muller, L.L. Xi, H.X. Liu, X.J. Yao, T. Oberg, F. Hormozdiari, P.H. Dao, C. Sahinalp, R. Todeschini, P. Polishchuk, A. Artemenko, V. Kuz’min, T.M. Martin, D.M. Young, D. Fourches, E. Muratov, A. Tropsha, I. Baskin, D. Horvath, G. Marcou, C. Muller, A. Varnek, V.V. Prokopenko, and I.V. Tetko, Applicability domains for classification problems: Benchmarking of distance to models for ames mutagenicity set, J. Chem. Inf. Model 50 (2010), pp. 2094–2111. doi:10.1021/ci100253r.
   PubMed Web of Science ®Google Scholar
• P. Gramatica, Principles of QSAR models validation: Internal and external, QSAR. Comb. Sci. 26 (2007), pp. 694–701. doi:10.1002/qsar.200610151.
   Google Scholar
• E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics 44 (1988), pp. 837–845. doi:10.2307/2531595.
   PubMed Web of Science ®Google Scholar
• A. Nicholls, Confidence limits, error bars and method comparison in molecular modeling. Part 2: Comparing methods, J. Comput. Aided Molec. Des. 30 (2016), pp. 103–126. doi:10.1007/s10822-016-9904-5.
   PubMed Web of Science ®Google Scholar
• Y. Benjamini and Y. Hochberg, Controlling the false discovery rate: A practical and powerful approach to multiple testing, J. R. Stat. Soc. B. 57 (1995), pp. 289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
   Google Scholar
• L. van der Maaten and G. Hinton, Visualizing data using t-sne, J. Mach. Learn. Res. 9 (2008), pp. 2579–2605. Available at https://www.jmlr.org/papers/volume9/vandermaaten08a/vandermaaten08a.pdf
   Web of Science ®Google Scholar
• T. Kanungo, D.M. Mount, N.S. Netanyahu, C.D. Piatko, R. Silverman, and A.Y. Wu, An efficient k-means clustering algorithm: Analysis and implementation, IEEE T. Pattern. Anal. 24 (2002), pp. 881–892. doi:10.1109/tpami.2002.1017616.
   Web of Science ®Google Scholar